Abstract Sun507: Artificial Intelligence Driven Subphenotyping of In-Hospital Cardiac Arrest Patients Identifies Subgroups with Different Outcomes and Risk Factors: A Nation-Wide Analysis

J Joy Jiang (Icahn School of Medicine at Mount Sinai, New York, New York, United States) W Wonsuk Oh (Icahn School of Medicine at Mount S, New York, New York, United States) D David Buckler (Icahn School of Med at Mount Sinai, New York, New York, United States) H Hannah Kittrell (Icahn School of Med at Mount Sinai, New York, New York, United States) P Pushkala Jayaraman (Icahn School of Med at Mount Sinai, New York, New York, United States) L Lili Chan A Akhil Vaid F Faris Gulamali (Icahn Sch. of Medicine at Mt. Sinai, New York City, New York, United States) M Michael Redlener (Icahn School of Med at Mount Sinai, New York, New York, United States) A alexis zebrowski (Icahn School of Med at Mount Sinai, New York, New York, United States) D Deepak Bhatt (Icahn School of Med at Mount Sinai, New York, New York, United States) G Girish Nadkarni E Ethan Abbott (Icahn School of Medicine at Mount Sinai, New York, New York, United States)

Abstract

Introduction: Disparities in outcomes after in-hospital cardiac arrest (IHCA) across race, ethnicity, and socioeconomic status are impacted by social determinants of health (SDOH) and health care access. We applied unsupervised machine learning methodologies to identify novel patient-level IHCA subphenotypes by integrating clinical and sociodemographic data, and safety-net hospital (SNH) status. Methods: We utilized a cohort of 431,847 patients who suffered an IHCA from the American Heart Association Get with the Guidelines-Resuscitation Registry that included demographic characteristics, resuscitation outcomes and processes, and SDOH features. We implemented K-means clustering and hierarchical clustering with factor analysis for mixed data to identify subphenotypes. The primary outcome was survival to discharge and survival with good neurological status as defined by cerebral performance category (CPC) 1-2. We then compared survival outcomes across subphenotypes using Cox proportional hazards models. Results: Subphenotype A (n = 307,668) consisted of patients with high burden of comorbidities and the highest rates of unmet social needs. This subphrnotype had the lowest survival to discharge (19.1%) and good neurological outcomes proportion (12.2%) as compared to other subphenotypes (Figure 1). Subphenotype B (n = 57,356) was composed of patients who experienced high rates of respiratory disease and primarily arrested in the emergency department. Subphenotype C (n = 66,823) were more likely to undergo intubation during resusciation and demonstrated the best survival to discharge proportion (43.6%) and good neurological outcomes (32.2%). Subphenotype assignment was independently associated with survival (HR 0.766, 95% CI 0.755–0.776) and good neurological outcomes (HR 0.770, 95% CI 0.757–0.783) (Figure 2). Subphenotype A patients were more likely to receive care at safety-net hospitals (20.1%) compared to subphenotype C (17.1%). Treatment at a SNH was an independent predictor of lower survival (AUROC 0.82) and poorer neurological recovery (AUROC 0.80) (Figure 3). Conclusion: Using a large IHCA registry we identified three IHCA subphenotypes with significant differences in survival and neurological outcomes. By combining hospital structural features with detailed clinical and resuscitation data, this study offers a better understanding of IHCA risk across institutions and populations to inform targeted interventions.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (13)

J

Joy Jiang

Icahn School of Medicine at Mount Sinai, New York, New York, United States

W

Wonsuk Oh

Icahn School of Medicine at Mount S, New York, New York, United States

D

David Buckler

Icahn School of Med at Mount Sinai, New York, New York, United States

H

Hannah Kittrell

Icahn School of Med at Mount Sinai, New York, New York, United States

P

Pushkala Jayaraman

Icahn School of Med at Mount Sinai, New York, New York, United States

L

Lili Chan

A

Akhil Vaid

F

Faris Gulamali

Icahn Sch. of Medicine at Mt. Sinai, New York City, New York, United States

M

Michael Redlener

Icahn School of Med at Mount Sinai, New York, New York, United States

A

alexis zebrowski

Icahn School of Med at Mount Sinai, New York, New York, United States

D

Deepak Bhatt

Icahn School of Med at Mount Sinai, New York, New York, United States

G

Girish Nadkarni

E

Ethan Abbott

Icahn School of Medicine at Mount Sinai, New York, New York, United States